TreeWAS – Variant ID: rs2704588

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
O02.1 Missed abortion	0.000	0.903	0.097
O02 Other abnormal products of conception	0.000	0.926	0.074
O03.9 Complete or unspecified, without complication	0.000	0.938	0.062
O03 Spontaneous abortion	0.000	0.940	0.060
O00-O08 Pregnancy with abortive outcome	0.000	0.940	0.060
O02.9 Abnormal product of conception, unspecified	0.000	0.946	0.053
O02.8 Other specified abnormal products of conception	0.000	0.946	0.053
O02.0 Blighted ovum and nonhydatidiform mole	0.000	0.948	0.051
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.955	0.045
O04 Medical abortion	0.000	0.955	0.045
O03.8 Complete or unspecified, with other and unspecified complications	0.000	0.957	0.043
O03.7 Complete or unspecified, complicated by embolism	0.000	0.957	0.043
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.957	0.043
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.957	0.043
O03.2 Incomplete, complicated by embolism	0.000	0.957	0.043
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.957	0.043
O07 Failed attempted abortion	0.000	0.957	0.043
O06 Unspecified abortion	0.000	0.957	0.043
O05 Other abortion	0.000	0.957	0.043
O01 Hydatidiform mole	0.000	0.957	0.043
O08 Complications following abortion and ectopic and molar pregnancy	0.000	0.959	0.041
O03.4 Incomplete, without complication	0.000	0.960	0.040
O03.3 Incomplete, with other and unspecified complications	0.000	0.960	0.040
O04.4 Incomplete, without complication	0.000	0.960	0.040
O04.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.966	0.034
O04.8 Complete or unspecified, with other and unspecified complications	0.000	0.967	0.033
O04.7 Complete or unspecified, complicated by embolism	0.000	0.967	0.033
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.967	0.033
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.967	0.033
O04.3 Incomplete, with other and unspecified complications	0.000	0.967	0.033
O04.2 Incomplete, complicated by embolism	0.000	0.967	0.033
O04.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.967	0.033
O01.9 Hydatidiform mole, unspecified	0.000	0.969	0.031
O01.1 Incomplete and partial hydatidiform mole	0.000	0.969	0.031
O01.0 Classical hydatidiform mole	0.000	0.969	0.031
O05.9 Complete or unspecified, without complication	0.000	0.969	0.031
O05.8 Complete or unspecified, with other and unspecified complications	0.000	0.969	0.031
O05.7 Complete or unspecified, complicated by embolism	0.000	0.969	0.031
O05.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.969	0.031
O05.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.969	0.031
O05.4 Incomplete, without complication	0.000	0.969	0.031
O05.3 Incomplete, with other and unspecified complications	0.000	0.969	0.031
O05.2 Incomplete, complicated by embolism	0.000	0.969	0.031
O05.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.969	0.031
O05.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.969	0.031
O06.9 Complete or unspecified, without complication	0.000	0.969	0.031
O06.8 Complete or unspecified, with other and unspecified complications	0.000	0.969	0.031
O06.7 Complete or unspecified, complicated by embolism	0.000	0.969	0.031
O06.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.969	0.031
O06.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.969	0.031
O06.4 Incomplete, without complication	0.000	0.969	0.031
O06.3 Incomplete, with other and unspecified complications	0.000	0.969	0.031
O06.2 Incomplete, complicated by embolism	0.000	0.969	0.031
O06.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.969	0.031
O06.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.969	0.031
O07.9 Other and unspecified failed attempted abortion, without complication	0.000	0.969	0.031
O07.8 Other and unspecified failed attempted abortion, with other and unspecified complications	0.000	0.969	0.031
O07.7 Other and unspecified failed attempted abortion, complicated by embolism	0.000	0.969	0.031
O07.6 Other and unspecified failed attempted abortion, complicated by delayed or excessive haemorrhage	0.000	0.969	0.031
O07.5 Other and unspecified failed attempted abortion, complicated by genital tract and pelvic infection	0.000	0.969	0.031
O07.4 Failed medical abortion, without complication	0.000	0.969	0.031
O07.3 Failed medical abortion, with other and unspecified complications	0.000	0.969	0.031
O07.2 Failed medical abortion, complicated by embolism	0.000	0.969	0.031
O07.1 Failed medical abortion, complicated by delayed or excessive haemorrhage	0.000	0.969	0.031
O07.0 Failed medical abortion, complicated by genital tract and pelvic infection	0.000	0.969	0.031
O08.1 Delayed or excessive haemorrhage following abortion and ectopic and molar pregnancy	0.000	0.969	0.030
O08.9 Complication following abortion and ectopic and molar pregnancy, unspecified	0.000	0.970	0.030
O08.8 Other complications following abortion and ectopic and molar pregnancy	0.000	0.970	0.030
O08.7 Other venous complications following abortion and ectopic and molar pregnancy	0.000	0.970	0.030
O08.6 Damage to pelvic organs and tissues following abortion and ectopic and molar pregnancy	0.000	0.970	0.030
O08.5 Metabolic disorders following abortion and ectopic and molar pregnancy	0.000	0.970	0.030
O08.4 Renal failure following abortion and ectopic and molar pregnancy	0.000	0.970	0.030
O08.3 Shock following abortion and ectopic and molar pregnancy	0.000	0.970	0.030
O08.2 Embolism following abortion and ectopic and molar pregnancy	0.000	0.970	0.030
O08.0 Genital tract and pelvic infection following abortion and ectopic and molar pregnancy	0.000	0.973	0.027
I20.9 Angina pectoris, unspecified	0.027	0.973	0.000
O00 Ectopic pregnancy	0.000	0.973	0.026
J32.9 Chronic sinusitis, unspecified	0.000	0.978	0.022
C91 Lymphoid leukaemia	0.020	0.980	0.000
O00.8 Other ectopic pregnancy	0.000	0.981	0.019
O00.2 Ovarian pregnancy	0.000	0.981	0.019
O00.0 Abdominal pregnancy	0.000	0.981	0.019
O04.9 Complete or unspecified, without complication	0.000	0.981	0.019
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.019	0.981	0.000
C91.1 Chronic lymphocytic leukaemia	0.019	0.981	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.018	0.982	0.000
C95 Leukaemia of unspecified cell type	0.018	0.982	0.000
C91.0 Acute lymphoblastic leukaemia	0.018	0.982	0.000
C91.4 Hairy-cell leukaemia	0.017	0.983	0.000
C95.9 Leukaemia, unspecified	0.017	0.983	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.016	0.984	0.000
H43.1 Vitreous haemorrhage	0.016	0.984	0.000
C81 Hodgkin's disease	0.016	0.984	0.000
C91.5 Adult T-cell leukaemia	0.016	0.984	0.000
O00.9 Ectopic pregnancy, unspecified	0.000	0.984	0.016
C93 Monocytic leukaemia	0.016	0.984	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.016	0.984	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.015	0.984	0.000
C92 Myeloid leukaemia	0.015	0.985	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.015	0.985	0.000
C91.7 Other lymphoid leukaemia	0.015	0.985	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.015	0.985	0.000
C91.3 Prolymphocytic leukaemia	0.015	0.985	0.000
C91.2 Subacute lymphocytic leukaemia	0.015	0.985	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.015	0.985	0.000
C85.1 B-cell lymphoma, unspecified	0.015	0.985	0.000
C91.9 Lymphoid leukaemia, unspecified	0.014	0.986	0.000
I20 Angina pectoris	0.014	0.986	0.000
I50.9 Heart failure, unspecified	0.014	0.986	0.000
C86 Other specified types of T/NK-cell lymphoma	0.014	0.986	0.000
H43 Disorders of vitreous body	0.014	0.986	0.000
C81.0 Lymphocytic predominance	0.014	0.986	0.000
C93.1 Chronic monocytic leukaemia	0.014	0.986	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.014	0.986	0.000
C94 Other leukaemias of specified cell type	0.014	0.986	0.000
C81.1 Nodular sclerosis	0.014	0.986	0.000
I20.8 Other forms of angina pectoris	0.014	0.986	0.000
C84.5 Other and unspecified T-cell lymphomas	0.013	0.987	0.000
C92.1 Chronic myeloid leukaemia	0.013	0.987	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.013	0.987	0.000
C85.0 Lymphosarcoma	0.013	0.987	0.000
C95.7 Other leukaemia of unspecified cell type	0.013	0.987	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.013	0.987	0.000
C95.0 Acute leukaemia of unspecified cell type	0.013	0.987	0.000
C92.9 Myeloid leukaemia, unspecified	0.013	0.987	0.000
J32.2 Chronic ethmoidal sinusitis	0.000	0.987	0.013
T92.9 Sequelae of unspecified injury of upper limb	0.013	0.987	0.000
J32 Chronic sinusitis	0.000	0.987	0.013
C88 Malignant immunoproliferative diseases	0.013	0.987	0.000
C81.2 Mixed cellularity	0.012	0.988	0.000
C81.7 Other Hodgkin's disease	0.012	0.988	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.012	0.988	0.000
C81.3 Lymphocytic depletion	0.012	0.988	0.000
C84.4 Peripheral T-cell lymphoma	0.012	0.988	0.000
T92 Sequelae of injuries of upper limb	0.012	0.988	0.000
C81.9 Hodgkin's disease, unspecified	0.012	0.988	0.000
H43.3 Other vitreous opacities	0.012	0.988	0.000
I20.1 Angina pectoris with documented spasm	0.012	0.988	0.000
C93.9 Monocytic leukaemia, unspecified	0.011	0.988	0.000
C93.7 Other monocytic leukaemia	0.011	0.988	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.011	0.988	0.000
C93.2 Subacute monocytic leukaemia	0.011	0.988	0.000
C93.0 Acute monocytic leukaemia	0.011	0.988	0.000
T92.1 Sequelae of fracture of arm	0.012	0.988	0.000
H43.9 Disorder of vitreous body, unspecified	0.011	0.988	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.011	0.989	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.011	0.989	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.011	0.989	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.011	0.989	0.000
C84.3 Lymphoepithelioid lymphoma	0.011	0.989	0.000
C84.2 T-zone lymphoma	0.011	0.989	0.000
C84.1 Sezary's diease	0.011	0.989	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.011	0.989	0.000
C92.7 Other myeloid leukaemia	0.011	0.989	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.011	0.989	0.000
C92.5 Acute myelomonocytic leukaemia	0.011	0.989	0.000
C92.4 Acute promyelocytic leukaemia	0.011	0.989	0.000
C92.3 Myeloid sarcoma	0.011	0.989	0.000
C92.2 Subacute myeloid leukaemia	0.011	0.989	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.011	0.989	0.000
C84.0 Mycosis fungoides	0.010	0.989	0.000
H43.8 Other disorders of vitreous body	0.011	0.989	0.000
H43.2 Crystalline deposits in vitreous body	0.010	0.990	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.010	0.990	0.000
C86.4 Blastic NK-cell lymphoma	0.010	0.990	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.010	0.990	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.010	0.990	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.010	0.990	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.010	0.990	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.010	0.990	0.000
H43.0 Vitreous prolapse	0.010	0.990	0.000
J32.1 Chronic frontal sinusitis	0.000	0.990	0.010
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.010	0.990	0.000
J32.0 Chronic maxillary sinusitis	0.000	0.990	0.010
C94.7 Other specified leukaemias	0.010	0.990	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.010	0.990	0.000
C94.5 Acute myelofibrosis	0.010	0.990	0.000
C94.4 Acute panmyelosis	0.010	0.990	0.000
C94.3 Mast cell leukaemia	0.010	0.990	0.000
C94.2 Acute megakaryoblastic leukaemia	0.010	0.990	0.000
C94.1 Chronic erythraemia	0.010	0.990	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.010	0.990	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.010	0.990	0.000
C96.8 Histiocytic sarcoma	0.010	0.990	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.010	0.990	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.010	0.990	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.010	0.990	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.010	0.990	0.000
C96.3 True histiocytic lymphoma	0.010	0.990	0.000
C96.2 Malignant mast cell tumour	0.010	0.990	0.000
C96.1 Malignant histiocytosis	0.010	0.990	0.000
C96.0 Letterer-Siwe disease	0.010	0.990	0.000
O00.1 Tubal pregnancy	0.000	0.990	0.009
T92.2 Sequelae of fracture at wrist and hand level	0.010	0.990	0.000
T92.0 Sequelae of open wound of upper limb	0.010	0.990	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.009	0.990	0.000
C88.7 Other malignant immunoproliferative diseases	0.009	0.990	0.000
C88.3 Immunoproliferative small intestinal disease	0.009	0.990	0.000
C88.2 Gamma heavy chain disease	0.009	0.990	0.000
C88.1 Alpha heavy chain disease	0.009	0.990	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.009	0.990	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.009	0.991	0.000
C90.2 Plasmacytoma, extramedullary	0.009	0.991	0.000
T92.4 Sequelae of injury of nerve of upper limb	0.009	0.991	0.000
D86.9 Sarcoidosis, unspecified	0.009	0.991	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.009	0.991	0.000
H43-H45 Disorders of vitreous body and globe	0.009	0.991	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.008	0.991	0.000
R59.1 Generalised enlarged lymph nodes	0.008	0.992	0.000
D86 Sarcoidosis	0.008	0.992	0.000
R59.9 Enlarged lymph nodes, unspecified	0.008	0.992	0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.008	0.992	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.008	0.992	0.000
J32.3 Chronic sphenoidal sinusitis	0.000	0.992	0.008
D80 Immunodeficiency with predominantly antibody defects	0.008	0.992	0.000
D80-D89 Certain disorders involving the immune mechanism	0.008	0.992	0.000
D86.1 Sarcoidosis of lymph nodes	0.008	0.992	0.000
H44 Disorders of globe	0.008	0.992	0.000
C83.7 Burkitt's tumour	0.008	0.992	0.000
J32.4 Chronic pansinusitis	0.000	0.992	0.007
C83.0 Small cell (diffuse)	0.007	0.993	0.000
R59 Enlarged lymph nodes	0.007	0.993	0.000
H44.2 Degenerative myopia	0.007	0.993	0.000
C92.0 Acute myeloid leukaemia	0.007	0.993	0.000
C90.1 Plasma cell leukaemia	0.007	0.993	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.007	0.993	0.000
J32.8 Other chronic sinusitis	0.000	0.993	0.007
C83.6 Undifferentiated (diffuse)	0.007	0.993	0.000
C83.5 Lymphoblastic (diffuse)	0.007	0.993	0.000
C83.4 Immunoblastic (diffuse)	0.007	0.993	0.000
C83.2 Mixed small and large cell (diffuse)	0.007	0.993	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.007	0.993	0.000
C90.3 Solitary plasmacytoma	0.007	0.993	0.000
M79.66 Pain in limb (Lower leg)	0.007	0.993	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.006	0.993	0.000
D82 Immunodeficiency associated with other major defects	0.006	0.993	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.006	0.993	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.006	0.994	0.000
C83.1 Small cleaved cell (diffuse)	0.006	0.994	0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.006	0.994	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.006	0.994	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.006	0.994	0.000
D46 Myelodysplastic syndromes	0.006	0.994	0.000
D86.8 Sarcoidosis of other and combined sites	0.006	0.994	0.000
H44.4 Hypotony of eye	0.006	0.994	0.000
D83 Common variable immunodeficiency	0.006	0.994	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.006	0.994	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.006	0.994	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.006	0.994	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.006	0.994	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.006	0.994	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.006	0.994	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.006	0.994	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.994	0.006
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.006	0.994	0.000
R59.0 Localised enlarged lymph nodes	0.006	0.994	0.000
D81 Combined immunodeficiencies	0.006	0.994	0.000
H44.0 Purulent endophthalmitis	0.006	0.994	0.000
H44.9 Disorder of globe, unspecified	0.006	0.994	0.000
H44.8 Other disorders of globe	0.006	0.994	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.006	0.994	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.006	0.994	0.000
H44.3 Other degenerative disorders of globe	0.006	0.994	0.000
Z03.5 Observation for other suspected cardiovascular diseases	0.006	0.994	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.006	0.994	0.000
H44.5 Degenerated conditions of globe	0.006	0.994	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.006	0.994	0.000
D46.4 Refractory anaemia, unspecified	0.006	0.994	0.000
T43.2 Other and unspecified antidepressants	0.000	0.994	0.006
D46.2 Refractory anaemia with excess of blasts	0.006	0.994	0.000
D82.1 Di George's syndrome	0.005	0.994	0.000
D84 Other immunodeficiencies	0.005	0.994	0.000
D46.1 Refractory anaemia with sideroblasts	0.005	0.994	0.000
D46.7 Other myelodysplastic syndromes	0.005	0.995	0.000
D89.1 Cryoglobulinaemia	0.005	0.995	0.000
H44.1 Other endophthalmitis	0.005	0.995	0.000
J38.3 Other diseases of vocal cords	0.005	0.995	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.005	0.995	0.000
D89.3 Immune reconstitution syndrome	0.005	0.995	0.000
Y44.2 Anticoagulants	0.005	0.995	0.000
D86.0 Sarcoidosis of lung	0.005	0.995	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.005	0.995	0.000
D86.3 Sarcoidosis of skin	0.005	0.995	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.005	0.995	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.005	0.995	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.005	0.995	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.005	0.995	0.000
D82.2 Immunodeficiency with short-limbed stature	0.005	0.995	0.000
D82.0 Wiskott-Aldrich syndrome	0.005	0.995	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.005	0.995	0.000
D83.9 Common variable immunodeficiency, unspecified	0.005	0.995	0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.005	0.995	0.000
H45.1 Endophthalmitis in diseases classified elsewhere	0.005	0.995	0.000
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.005	0.995	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.005	0.995	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.005	0.995	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.005	0.995	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.005	0.995	0.000
D83.8 Other common variable immunodeficiencies	0.004	0.995	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.004	0.995	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.004	0.995	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.004	0.995	0.000
D81.9 Combined immunodeficiency, unspecified	0.004	0.995	0.000
D81.8 Other combined immunodeficiencies	0.004	0.995	0.000
D81.7 Major histocompatibility complex class II deficiency	0.004	0.995	0.000
D81.6 Major histocompatibility complex class I deficiency	0.004	0.995	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.004	0.995	0.000
D81.4 Nezelof's syndrome	0.004	0.995	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.004	0.995	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.004	0.995	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.004	0.995	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.004	0.995	0.000
C82.0 Small cleaved cell, follicular	0.004	0.996	0.000
J38.4 Oedema of larynx	0.004	0.996	0.000
J38.7 Other diseases of larynx	0.004	0.996	0.000
D84.8 Other specified immunodeficiencies	0.004	0.996	0.000
D84.1 Defects in the complement system	0.004	0.996	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.004	0.996	0.000
C53.9 Cervix uteri, unspecified	0.004	0.996	0.000
C83.3 Large cell (diffuse)	0.004	0.996	0.000
I78.1 Naevus, nonneoplastic	0.000	0.996	0.004
C71.2 Temporal lobe	0.004	0.996	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.004	0.996	0.000
N95.8 Other specified menopausal and perimenopausal disorders	0.004	0.996	0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.004	0.996	0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.004	0.996	0.000
C71 Malignant neoplasm of brain	0.004	0.996	0.000
C82.6 Cutaneous follicle centre lymphoma	0.004	0.996	0.000
C82.5 Diffuse follicle centre lymphoma	0.004	0.996	0.000
D84.9 Immunodeficiency, unspecified	0.004	0.996	0.000
C82.4 Follicular lymphoma grade IIIb	0.004	0.996	0.000
T91.9 Sequelae of unspecified injury of neck and trunk	0.004	0.996	0.000
Y83.8 Other surgical procedures	0.004	0.996	0.000
C71.9 Brain, unspecified	0.004	0.996	0.000
T91 Sequelae of injuries of neck and trunk	0.004	0.996	0.000
I84.4 External haemorrhoids with other complications	0.004	0.996	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.996	0.004
C71.4 Occipital lobe	0.004	0.996	0.000
C71.1 Frontal lobe	0.004	0.996	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.996	0.000
C82.3 Follicular lymphoma grade IIIa	0.003	0.996	0.000
I20.0 Unstable angina	0.004	0.996	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
N42.9 Disorder of prostate, unspecified	0.003	0.997	0.000
T90.9 Sequelae of unspecified injury of head	0.000	0.997	0.003
C82.2 Large cell, follicular	0.003	0.997	0.000
J38.2 Nodules of vocal cords	0.003	0.997	0.000
I50 Heart failure	0.003	0.997	0.000
C71.8 Overlapping lesion of brain	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
N42.8 Other specified disorders of prostate	0.003	0.997	0.000
C71.7 Brain stem	0.003	0.997	0.000
C71.6 Cerebellum	0.003	0.997	0.000
C71.5 Cerebral ventricle	0.003	0.997	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.003	0.997	0.000
C71.0 Cerebrum, except lobes and ventricles	0.003	0.997	0.000
K66.0 Peritoneal adhesions	0.000	0.997	0.003
T91.3 Sequelae of injury of spinal cord	0.003	0.997	0.000
C71.3 Parietal lobe	0.003	0.997	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.003	0.997	0.000
J38.6 Stenosis of larynx	0.003	0.997	0.000
T90.5 Sequelae of intracranial injury	0.000	0.997	0.003
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.003	0.997	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.003	0.997	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.003	0.997	0.000
S32.0 Fracture of lumbar vertebra	0.000	0.997	0.003
N71.9 Inflammatory disease of uterus, unspecified	0.003	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.997	0.001
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
I50.0 Congestive heart failure	0.003	0.997	0.000
J38.0 Paralysis of vocal cords and larynx	0.003	0.997	0.000
T91.2 Sequelae of other fracture of thorax and pelvis	0.003	0.997	0.000
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome	0.003	0.997	0.000
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.003	0.997	0.000
N42 Other disorders of prostate	0.003	0.997	0.000
X59.3 Sports and athletics area	0.000	0.997	0.003
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
D13.1 Stomach	0.003	0.997	0.000
T90 Sequelae of injuries of head	0.000	0.997	0.002
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.003	0.997	0.000
M65.84 Other synovitis and tenosynovitis (Hand)	0.003	0.997	0.000
O62.2 Other uterine inertia	0.003	0.997	0.000
T95 Sequelae of burns, corrosions and frostbite	0.002	0.998	0.000
T83.1 Mechanical complication of other urinary devices and implants	0.002	0.998	0.000
X59.2 School, other institution and public administrative area	0.000	0.998	0.002
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
S32.01 Fracture of lumbar vertebra (open)	0.000	0.998	0.002
N42.3 Dysplasia of prostate	0.002	0.998	0.000
O62 Abnormalities of forces of labour	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
T90.4 Sequelae of injury of eye and orbit	0.000	0.998	0.002
K55.9 Vascular disorder of intestine, unspecified	0.002	0.998	0.000
N42.2 Atrophy of prostate	0.002	0.998	0.000
O62.9 Abnormality of forces of labour, unspecified	0.002	0.998	0.000
O62.3 Precipitate labour	0.002	0.998	0.000
X59 Exposure to unspecified factor	0.000	0.998	0.002
H50.5 Heterophoria	0.002	0.998	0.000
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.002	0.998	0.000
J38.5 Laryngeal spasm	0.002	0.998	0.000
N80.9 Endometriosis, unspecified	0.002	0.998	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.998	0.002
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
K55.1 Chronic vascular disorders of intestine	0.002	0.998	0.000
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
T91.1 Sequelae of fracture of spine	0.002	0.998	0.000
T94 Sequelae of injuries involving multiple and unspecified body regions	0.002	0.998	0.001
T90.3 Sequelae of injury of cranial nerves	0.000	0.998	0.002
N47 Redundant prepuce, phimosis and paraphimosis	0.000	0.998	0.002
N42.1 Congestion and haemorrhage of prostate	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
C53 Malignant neoplasm of cervix uteri	0.002	0.998	0.000
T95.2 Sequelae of burn, corrosion and frostbite of upper limb	0.002	0.998	0.000
T90.0 Sequelae of superficial injury of head	0.000	0.998	0.002
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.002	0.998	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.000	0.998	0.002
J35.1 Hypertrophy of tonsils	0.000	0.998	0.002
T95.9 Sequelae of unspecified burn, corrosion and frostbite	0.002	0.998	0.000
T95.8 Sequelae of other specified burn, corrosion and frostbite	0.002	0.998	0.000
T95.4 Sequelae of burn and corrosion classifiable only according to extent of body surface involved	0.002	0.998	0.000
T95.3 Sequelae of burn, corrosion and frostbite of lower limb	0.002	0.998	0.000
T95.1 Sequelae of burn, corrosion and frostbite of trunk	0.002	0.998	0.000
T95.0 Sequelae of burn, corrosion and frostbite of head and neck	0.002	0.998	0.000
K55.2 Angiodysplasia of colon	0.002	0.998	0.000
Z96.0 Presence of urogenital implants	0.002	0.998	0.000
O66 Other obstructed labour	0.002	0.998	0.000
T98 Sequelae of other and unspecified effects of external causes	0.002	0.998	0.000
X59.4 Street and highway	0.000	0.998	0.002
H50.0 Convergent concomitant strabismus	0.002	0.998	0.000
J38.1 Polyp of vocal cord and larynx	0.002	0.998	0.000
O61.0 Failed medical induction of labour	0.002	0.998	0.000
O62.8 Other abnormalities of forces of labour	0.002	0.998	0.000
T83.2 Mechanical complication of graft of urinary organ	0.002	0.998	0.000
C67.4 Posterior wall of bladder	0.002	0.998	0.000
O62.0 Primary inadequate contractions	0.002	0.998	0.000
O75.2 Pyrexia during labour, not elsewhere classified	0.002	0.998	0.000
T90.8 Sequelae of other specified injuries of head	0.000	0.998	0.001
T90.1 Sequelae of open wound of head	0.000	0.998	0.001
T94.0 Sequelae of injuries involving multiple body regions	0.001	0.998	0.000
X59.9 Unspecified place	0.000	0.998	0.002
X59.8 Other specified place	0.000	0.998	0.002
X59.0 Home	0.000	0.998	0.002
X59.7 Farm	0.000	0.998	0.002
X59.6 Industrial and construction area	0.000	0.998	0.002
X59.5 Trade and service area	0.000	0.998	0.002
X59.1 Residential institution	0.000	0.998	0.002
I78 Diseases of capillaries	0.000	0.998	0.002
T83.9 Unspecified complication of genito-urinary prosthetic device, implant and graft	0.002	0.998	0.000
H50 Other strabismus	0.002	0.998	0.000
K55 Vascular disorders of intestine	0.002	0.998	0.000
O62.1 Secondary uterine inertia	0.002	0.998	0.000
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract	0.002	0.998	0.000
H92.0 Otalgia	0.002	0.998	0.000
M16.0 Primary coxarthrosis, bilateral	0.002	0.998	0.000
O66.2 Obstructed labour due to unusually large foetus	0.002	0.998	0.000
T83.3 Mechanical complication of intra-uterine contraceptive device	0.002	0.998	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.000	0.998	0.002
Z08 Follow-up examination after treatment for malignant neoplasm	0.002	0.998	0.000
N42.0 Calculus of prostate	0.002	0.998	0.000
C53.8 Overlapping lesion of cervix uteri	0.002	0.998	0.000
C53.1 Exocervix	0.002	0.998	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.002	0.998	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.998	0.002
A41.1 Septicaemia due to other specified staphylococcus	0.002	0.998	0.000
H50.9 Strabismus, unspecified	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.002	0.998	0.000
C53.0 Endocervix	0.002	0.998	0.000
Z35.5 Supervision of elderly primigravida	0.002	0.998	0.000
H50.6 Mechanical strabismus	0.002	0.998	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.002	0.998	0.000
M86.66 Other chronic osteomyelitis (Lower leg)	0.002	0.998	0.000
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.998	0.002
C90.0 Multiple myeloma	0.001	0.998	0.000
M07.3 Other psoriatic arthropathies	0.002	0.998	0.000
O66.9 Obstructed labour, unspecified	0.002	0.998	0.000
O66.8 Other specified obstructed labour	0.002	0.998	0.000
O66.4 Failed trial of labour, unspecified	0.002	0.998	0.000
O66.3 Obstructed labour due to other abnormalities of foetus	0.002	0.998	0.000
O66.1 Obstructed labour due to locked twins	0.002	0.998	0.000
T98.2 Sequelae of certain early complications of trauma	0.001	0.998	0.000
T98.0 Sequelae of effects of foreign body entering through natural orifice	0.001	0.998	0.000
F43.2 Adjustment disorders	0.000	0.998	0.002
M19.90 Arthrosis, unspecified (Multiple sites)	0.000	0.998	0.002
H50.1 Divergent concomitant strabismus	0.002	0.998	0.000
X59.09 Exposure to unspecified factor causing fracture; Unspecified place;	0.000	0.998	0.001
X59.88 Exposure to unspecified factor; Other specified places ;While engaged in other specified activities	0.000	0.998	0.001
X59.99 Exposure to unspecified factor causing other and unspecified injury, Unspecified place	0.000	0.998	0.001
I78.9 Disease of capillaries, unspecified	0.000	0.998	0.002
H50.3 Intermittent heterotropia	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations